Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 0 | 0 | 0 | 19 | 0 |
| Gross Profit | N/A | N/A | N/A | 19 | N/A |
| Operating Expenses | 8,244 | 7,971 | 8,358 | 7,905 | 8,093 |
| Operating Income | -8,244 | -7,971 | -8,358 | -7,887 | -8,093 |
| Other Income | 102 | 40 | 30 | 32 | 22 |
| Pre-tax Income | -8,142 | -7,931 | -8,329 | -7,855 | -8,072 |
| Net Income Continuous | -8,142 | -7,931 | -8,329 | -7,855 | -8,072 |
| Net Income | $-8,142 | $-7,931 | $-8,329 | $-7,855 | $-8,072 |
| EPS Basic Total Ops | -30.00 | -34.00 | -35.00 | -34.00 | -41.00 |
| EPS Basic Continuous Ops | -29.89 | -33.78 | -35.18 | -34.08 | -40.78 |
| EPS Diluted Total Ops | -30.00 | -34.00 | -35.00 | -34.00 | -41.00 |
| EPS Diluted Continuous Ops | -29.89 | -33.78 | -35.18 | -34.08 | -40.78 |
| EBITDA(a) | $-8,174 | $-7,917 | $-8,308 | $-7,841 | $-8,047 |